@article{3164137,
    title = "Circulating Biomarkers Determining Inflammation in Atherosclerosis
Progression",
    author = "Siasos, Gerasimos and Tsigkou, Vicky and Oikonomou, Evangelos and and Zaromitidou, Marina and Tsalamandris, Sotiris and Mourouzis, and Konstantinos and Vavuranakis, Manolis and Anastasiou, Maria and Vlasis, and Konstantinos and Limperi, Maria and Gennimata, Vasiliki and Boletis, and John N. and Papavassiliou, Athanasios G. and Tousoulis, Dimitris",
    journal = "Current Medicinal Chemistry",
    year = "2015",
    volume = "22",
    number = "22",
    pages = "2619-2635",
    publisher = "BENTHAM SCIENCE PUBL LTD",
    issn = "0929-8673",
    doi = "10.2174/0929867322666150415125828",
    keywords = "Atherosclerosis; biological markers; cardiovascular diseases;
cardiovascular risk; cytokines; inflammation; interleukins",
    abstract = "Atherosclerosis is the main underlying pathology of cardiovascular
disease and is precipitated by various hereditary and non-hereditary
risk factors. Inflammation is considered an important step in the
progression of atherosclerosis and involves numerous cells, mediators
and cellular procedures. Therefore, a biomarker able to determine the
vascular inflammatory status is imperative as the combination of
inflammatory biomarkers with the classic risk factors might provide
further information about atherosclerosis progression and cardiovascular
risk. The identification of novel inflammatory molecules and the
improvement in analytical methods allows the potential implementation of
these tests in every day clinical practice. In the current article, we
focus on the role of established and novel biomarkers in atherosclerosis
progression and in the determination of cardiovascular risk. We also
present recent data concerning the risk stratification of patients
according to their inflammatory status and the possible
anti-inflammatory treatment strategies."
}